Unlock instant, AI-driven research and patent intelligence for your innovation.

Cyclodextrin-camptothecin type supermolecules chemotherapeutic drugs, and preparation and applications thereof

A technology of cyclodextrin and camptothecin, applied in the field of biomedical technology, supramolecular chemistry and drug controlled release, and nanomedicine, can solve the problem of drug efficacy decline

Active Publication Date: 2017-07-04
YANTAI LANNACHENG BIOTECHNOLOGY CO LTD
View PDF3 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

On the other hand, the lactone form in these drugs is easily hydrolyzed into a carboxyl structure during blood circulation, resulting in a sharp drop in drug efficacy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cyclodextrin-camptothecin type supermolecules chemotherapeutic drugs, and preparation and applications thereof
  • Cyclodextrin-camptothecin type supermolecules chemotherapeutic drugs, and preparation and applications thereof
  • Cyclodextrin-camptothecin type supermolecules chemotherapeutic drugs, and preparation and applications thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0083] Embodiment 1: the preparation of CPT-S-S-OH (1)

[0084] With stirring at room temperature, 4-dimethylaminopyridine (2.10 g, 17.2 mmol) was added to a solution of camptothecin (2.00 g, 5.74 mmol) in dichloromethane. After continuing to stir for 30 minutes, triphosgene (0.633 g, 2.12 mmol) was added slowly. After stirring for 1 hour, 2,2'-dithiodiethanol (17.2 g, 117 mmol) was added dropwise, and the reaction solution was stirred overnight at room temperature. The mixture was washed three times with saturated brine (100 mL), and the dichloromethane organic phase obtained by separation was dried over anhydrous sodium sulfate. The product was purified by flash chromatography using a prepacked silica column. Yield: 2.12 g (70% yield). 1 H NMR (300MHz, CDCl 3 ): 8.46 (s, 1H), 8.22 (d, J=8.3Hz, 1H), 7.99 (dd, J=8.2, 1.1Hz, 1H), 7.86 (ddd, J=6.9, 6.5Hz, 1H), 7.70 (ddd, J=8.1, 6.9, 1.2Hz, 1H), 7.42(s, 1H), 5.64(d, J=18Hz, 1H), 5.36(m, 1H)4.37(t, J=6.0Hz, 2H) , 3.93-3.81 (...

Embodiment 2

[0085] Embodiment 2: the preparation of CPT-S-S-COOH (2)

[0086] Dissolve the CPT-S-S-OH (300mg, 0.552mmol) prepared by Example Method 1 in anhydrous dichloromethane under stirring, add succinic anhydride (1.00g, 10.0mmol) and a small amount of 4-dimethylaminopyridine respectively (21.0mg, 0.172mmol), the reaction solution was stirred overnight at room temperature. After the solution was dried, the solid was washed with water (100 mL) three times, and dried in vacuo to obtain the product CPT-S-S-COOH (yield 88%). 1 H NMR (300MHz, CDCl 3 ): 8.44 (s, 1H), 8.32 (d, J = 8.4Hz, 1H), 7.95 (d, J = 8.2Hz, 1H), 7.84 (ddd, J = 8.5, 6.9, 1.4Hz, 1H), 7.69 (ddd, J=8.1, 7.0, 1.1Hz, 1H), 7.43(s, 1H), 5.71(d, J=17.3Hz, 1H), 5.39(d, J=17.3Hz, 1H), 5.32(s, 2H), 4.46-4.25 (m, 4H), 3.00-2.86 (m, 4H), 2.79-2.61 m, 2H), 1.01 (t, J=7.5, 3H). ESI-MS m / z: calculated value 628.12, found value 629.10 (M+H) + . figure 2 for CPT-S-S-COOH 1 The H NMR spectrum proves that the compound was successfu...

Embodiment 3

[0087] Embodiment 3: the preparation of CD-S-S-CPT

[0088] The CPT-S-S-COOH (628 mg, 1.00 mmol) prepared by the method in Example 2 was dissolved in 100 ml of anhydrous dichloromethane. Add N-hydroxysuccinimide (0.575g, 5.00mmol), 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC.HCl, 1.91g, 10.0mmol ), stirred at room temperature for 1 day. The organic solvent was removed using a rotary evaporator, and the mixture was washed 3 times with chilled methanol (100 mL). The obtained white solid (363mg, 0.500mmol) was dissolved in DMF (20ml), 6-ethylamino-β-cyclodextrin (1.18g, 1.00mmol) and three drops of triethylamine were added respectively, and stirred overnight at room temperature. The solution was poured into 100 ml of acetone, suction filtered to obtain a light yellow solid, washed three times with dichloromethane (100 ml), washed three times with water (50 ml), and the solid was drained to obtain the product CD-S-S-CPT (yield 74%). 1 H NMR (300MHz, CDCl 3 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

Camptothecin-cyclodextrin type prodrugs are provided. The general structure formula of the prodrugs is shown as a formula (I), wherein n1 is integer from 1 to 3, R1 is shown in the specification, R2 is shown in the specification, R3 is shown in the specification, R4 is camptothecin or derivative groups thereof, X is S or -CH2-, and n2, n3 and n4 are integers from 0 to 10. The prodrugs can be self-assemblied in an aqueous solution to form nanometer particles and have excellent antitumor activity and low toxicity to normal tissues. A preparing method of the prodrugs and applications of the prodrugs in preparation of cancer-treating drugs are also provided.

Description

technical field [0001] The invention relates to the technical fields of biomedicine technology, nano medicine, supramolecular chemistry and drug controlled release, in particular to a preparation method and application of a cyclodextrin-camptothecin class prodrug with tumor-specific reductive degradation drug . Background technique [0002] Cancer, also known as malignant tumor, has become the main cause of threats to human survival and health, and is the second leading cause of death in the world. According to the World Health Organization, cancer caused about 8.8 million deaths in 2015, accounting for one-sixth of the global mortality rate. Approximately 70% of cancer deaths occur in low- and middle-income countries due to insufficient resources for diagnosis and treatment. Treating cancer and improving the survival rate and quality of life of cancer patients have become a worldwide problem. Currently, chemotherapy is still one of the main methods of cancer treatment. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C08B37/16A61K31/724A61P35/00
CPCC08B37/0012C08B37/0015
Inventor 陈小元俞国灿
Owner YANTAI LANNACHENG BIOTECHNOLOGY CO LTD